RaySearch Laboratories AB (publ)
RSLBF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $9 | $10 | $8 | $7 |
| - Cash | $0 | $0 | $1 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $9 | $10 | $8 | $7 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 9% | -8.1% | 2.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 96.4% | 90.8% | 92% | 92.3% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 26.8% | 11.9% | 22.6% | 22.8% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 21.5% | 10.1% | 17.1% | 18.6% |
| EPS Diluted | 2.09 | 0.9 | 1.66 | 1.75 |
| % Growth | 132.2% | -45.8% | -5.1% | – |
| Operating Cash Flow | -$0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | $0 | $0 |